Up to 33% of the general population at any one time are colonised with
Staphylococcus aureus (including MRSA) on areas of their body, e.g. nose,
skin, axilla, groin.
- MRSA is methicillin-resistant Staphylococcus aureus,
a potentially dangerous type of staph bacteria
- It is
resistant to certain antibiotics and may cause skin and
MRSA is not usually a risk to healthy people.
- Research has shown that
healthcare workers, who become colonised, have acquired the bacteria
through their work
- The MRSA is usually present for a short time only.
- MRSA will not be susceptible to flucloxacillin and possibly a range of other antibiotics.
Patients at risk
- Patients with an underlying illness.
- Older people – particularly if they have a chronic illness.
- The very ill – patients in intensive care.
- Those with open wounds or who have had major surgery.
- Patients with invasive devices such as urinary catheters.
- Body and hair treatment: An antibacterial solution for body and hair treatment, e.g. Octenisan, Hibiscrub, or Prontoderm Foam (see Appendix 2), daily for 5 days, following the manufacturer’s instructions. The use of Hibiscrub is not advised,
therefore, use Octenisan or Prontoderm Foam, daily for 5 days
- Nasal treatment: Nasal Mupirocin 2% ointment, e.g. Bactroban nasal, three times a day for 5 days. For patients who have a resistance to Mupirocin, Naseptin nasal ointment should be used 4 times a day for 10 days, following the manufacturer’s instructions
- For patients known to be MRSA positive or who have risk factors replace amoxicillin or flucloxacillin with IV Teicoplanin 400mg IV (600mg if patient is >100kg)
- For those who have MRSA sepsis also consider adding IV Vancomycin 1 g BD given over 100 mins, Assumes normal renal function